Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study.

Autor: Lin S; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Lei S; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Liu W; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Zhu X; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Yin L; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Liu Q; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China., Feng B; The Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China. fengbianling@163.com.; The Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, Shaanxi, China. fengbianling@163.com.

Publikováno v: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Oct; Vol. 46 (5), pp. 1076-1090. Date of Electronic Publication: 2024 May 10.

Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database.

Autor: Wang Z; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China., Lu H; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China., Li Y; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China., Huang S; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China., Zhang M; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China., Wen Y; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China. Electronic address: wenyuguande@163.com., Shang D; The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China. Electronic address: shang_dewei@163.com.

Publikováno v: Journal of affective disorders [J Affect Disord] 2024 Dec 15; Vol. 367, pp. 96-108. Date of Electronic Publication: 2024 Aug 30.

Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence.

Autor: Zhou J; Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xinquan Rd. Gulou District, Fuzhou, Fujian 350001, China; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Electronic address: zhoujianxing@fjmu.edu.cn., Chen Z; Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian, China., Zhang M; State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China., Ye Y; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China., Shen Y; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China., Wu X; Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xinquan Rd. Gulou District, Fuzhou, Fujian 350001, China; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Electronic address: wuxuemei@fjmu.edu.cn.

Publikováno v: Seizure [Seizure] 2024 Dec; Vol. 123, pp. 26-33. Date of Electronic Publication: 2024 Oct 16.

Cardiovascular adverse events associated with norepinephrine-dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Autor: Kandukuru A; Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, USA., Sharma P; Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, USA., Verghese Gupta S; Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, USA., Nkembo A; Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, USA., Sutariya V; Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, USA.

Publikováno v: Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2024 Dec 01; Vol. 102 (12), pp. 709-719. Date of Electronic Publication: 2024 Oct 21.

Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system.

Autor: Xu B; School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.; The First Affiliated Hospital, Hunan Provincial Clinical Medical Research Center for Drug Evaluation of Major Chronic Diseases, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.; The First Affiliated Hospital, Hengyang Clinical Pharmacology Research Center, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.; The First Affiliated Hospital, Hengyang Key Laboratory of Clinical Pharmacology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.; The First Affiliated Hospital, Pharmacy Department, University of South China, Hengyang, 421001, Hunan, China., Zhou J; School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.; The First Affiliated Hospital, Hunan Provincial Clinical Medical Research Center for Drug Evaluation of Major Chronic Diseases, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.; The First Affiliated Hospital, Hengyang Clinical Pharmacology Research Center, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.; The First Affiliated Hospital, Hengyang Key Laboratory of Clinical Pharmacology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.; The First Affiliated Hospital, Pharmacy Department, University of South China, Hengyang, 421001, Hunan, China. zhoujiecan@fsyy.usc.edu.cn.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Dec; Vol. 80 (12), pp. 1959-1966. Date of Electronic Publication: 2024 Sep 17.